Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Circulation
|
November 16, 2005
Supranormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure: insights from creatine transporter-overexpressing transgenic mice
Julie Wallis, Craig A Lygate, Alexandra Fischer, et al.
Journal of Molecular and Cellular Cardiology
|
November 17, 2009
Mice over-expressing the myocardial creatine transporter develop progressive heart failure and show decreased glycolytic capacity
Darci Phillips, Michiel Ten Hove, Jurgen E Schneider, et al.
Cardiovascular Research
|
August 24, 2012
Moderate elevation of intracellular creatine by targeting the creatine transporter protects mice from acute myocardial infarction
Craig A Lygate, Steffen Bohl, Michiel ten Hove, et al.
Diabetes
|
June 29, 2004
Polymorphisms in type II SH2 domain-containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome
Pamela J Kaisaki, Marc Delépine, Peng Y Woon, et al.
Circulation Research
|
January 18, 2013
Living without creatine: unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice
Craig A Lygate, Dunja Aksentijevic, Dana Dawson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 23, 2016
On the pivotal role of PPARα in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury
Mark A Cole, Amira H Abd Jamil, Lisa C Heather, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Circulation
|
November 16, 2005
Supranormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure: insights from creatine transporter-overexpressing transgenic mice
Julie Wallis, Craig A Lygate, Alexandra Fischer, et al.
Journal of Molecular and Cellular Cardiology
|
November 17, 2009
Mice over-expressing the myocardial creatine transporter develop progressive heart failure and show decreased glycolytic capacity
Darci Phillips, Michiel Ten Hove, Jurgen E Schneider, et al.
Cardiovascular Research
|
August 24, 2012
Moderate elevation of intracellular creatine by targeting the creatine transporter protects mice from acute myocardial infarction
Craig A Lygate, Steffen Bohl, Michiel ten Hove, et al.
Diabetes
|
June 29, 2004
Polymorphisms in type II SH2 domain-containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome
Pamela J Kaisaki, Marc Delépine, Peng Y Woon, et al.
Circulation Research
|
January 18, 2013
Living without creatine: unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice
Craig A Lygate, Dunja Aksentijevic, Dana Dawson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 23, 2016
On the pivotal role of PPARα in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury
Mark A Cole, Amira H Abd Jamil, Lisa C Heather, et al.
Page
of 2